SLCO1B1 Variants and The Risk of Antituberculosis Drug-induced Hepatotoxicity: A Systematic Review and Meta-analysis
Pharmacogenomics · 2009
DOI: 10.2217/pgs-2023-0168 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Pharmacogenomics, 2009. Verfasst von Min Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, 211166, China. Hauptthemen laut MEDLINE: Genetic Predisposition to Disease, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, 211166, China.
ORCID-Profile: Shaowen Tang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhu, M., Chen, X., Hao, Z., He, Y., Han, B., & Tang, S. (2009). SLCO1B1 Variants and The Risk of Antituberculosis Drug-induced Hepatotoxicity: A Systematic Review and Meta-analysis. Pharmacogenomics. https://doi.org/10.2217/pgs-2023-0168
Vancouver
Zhu M, Chen X, Hao Z, He Y, Han B, Tang S. SLCO1B1 Variants and The Risk of Antituberculosis Drug-induced Hepatotoxicity: A Systematic Review and Meta-analysis. Pharmacogenomics. 2009. doi:10.2217/pgs-2023-0168
BibTeX
@article{Zhu2009,
author = {Zhu, Min and Chen, Xinyu and Hao, Zhuolu and He, Yiwen and Han, Bing and Tang, Shaowen},
title = {SLCO1B1 Variants and The Risk of Antituberculosis Drug-induced Hepatotoxicity: A Systematic Review and Meta-analysis},
journal = {Pharmacogenomics},
year = {2009},
doi = {10.2217/pgs-2023-0168}
}
EUVIMED